Form D · Biotechnology

RetroSense Therapeutics, LLC

Ann Arbor, MI · CIK 0001520439

Offering snapshot reported Oct 13, 2015 · SEC filing

Reported sold
$4.56M
Offering amount: $5M
Investors reported
22
Form D · investor count
Minimum accepted
$4
Reported outside-investor minimum
First sale
Aug 19, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.28M$4.56MAug 31, 2015: $2,325,249.00Aug 31, 2015Oct 13, 2015: $4,562,255.00Oct 13, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,325,249 → $4,562,255
  • Reported investors21 → 22

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2015Amendment$4,562,255$2,237,006vs Aug 31, 201522SEC filing
Aug 31, 2015Initial$2,325,249No comparison21SEC filing
Oct 7, 2011Initial$75,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-246735

Source: Form D, filed Oct 13, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sean Ainsworth Director, Executive
Terry Cross Director
Cam Gallagher Director
Kenneth Kousky Director
George Lasezkay Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
330 E. Liberty Street
Ann Arbor, MI, 48104